权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Hepatitis B virus e antigen in viral persistence

乙型肝炎病毒e抗原在病毒持续存在中

基本信息

批准号：
10650689
负责人：
J.-H. James Ou
金额：
$ 49.5万
依托单位：
UNIVERSITY OF SOUTHERN CALIFORNIA
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
起止时间：
2017-02-20 至 2028-01-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10650689
关键词：
Affect Anti-Inflammatory Agents Binding Birth CD8-Positive T-Lymphocytes Cell Separation Cessation of life Chronic Chronic Hepatitis B Cirrhosis Clinical Discipline of Nursing Female Genes Genomic DNA Glutamates Glutaminase Glycolysis Goals Grant Hepatic Hepatitis B Therapy Hepatitis B Virus Hepatitis B e Antigens Hepatocyte Impairment Inflammatory Injections Knowledge Kupffer Cells Length Life Liver Liver diseases Macrophage Mediating Metabolic Metabolism Modeling Mothers Mus Names Oxidative Phosphorylation Patients Persons Play Pregnancy Primary carcinoma of the liver cells Productivity Proteins Regulation Research Role Signal Pathway T cell response TLR4 gene Testing Training Transgenic Mice Viral Viral Genome Virus Virus Replication analog anti-hepatitis B attenuation chronic infection e Antigens human pathogen improved in utero male metabolic profile metabolomics mouse model offspring programs receptor response viral DNA

项目摘要

Abstract Hepatitis B virus (HBV) is one of the most important human pathogens. There are approximately 300 million chronic HBV carriers in the world, resulting in nearly 1 million deaths every year. Most chronic HBV carriers acquired the virus from their infected mother early in life. HBV has a very narrow host range, which has greatly hampered its research. By crossing female hemizygous HBV transgenic mice that carry the 1.3mer overlength HBV genome to male naïve mice, we had developed a mouse model to study the mechanism of HBV persistence. We found that the persistence of HBV in mice was dependent on the HBV e antigen (HBeAg) and Kupffer cells, the resident macrophages of the liver. The requirement of HBeAg for HBV persistence is consistent with the clinical observation that the HBV persistence in babies is dependent on the HBeAg-positivity of their mothers. Our recent studies revealed an interesting interplay between HBeAg and hepatic macrophages. This interplay can either promote the HBV persistence or HBV clearance. In this application, we will continue to study this interplay between HBeAg and macrophages to understand the mechanism of HBV persistence. We had recently discovered that HBeAg could reprogram the metabolism of macrophages to promote the oxidative phosphorylation (OXPHOS). This metabolic reprogramming by HBeAg appears to be important for the attenuation of pro-inflammatory activities of Kupffer cells. We will therefore continue to study how HBeAg reprograms the metabolism of macrophages and study the implication of this reprogramming in the anti-HBV response. Our preliminary results also indicated that the toll-like receptor 4 (TLR4) mediated the effects of HBeAg on Kupffer cells. Thus, we will also investigate whether TLR4 serves as the receptor of HBeAg and its role in HBV persistence. Finally, we will determine whether HBeAg by itself is sufficient to promote HBV persistence and whether HBeAg can train Kupffer cells in utero to promote HBV persistence. Our proposed studies will provide important information for us to understand the mechanism of HBV persistence and help to improve the treatments for chronic HBV patients.

摘要